Tapewire

NYSE · USD

INSP

Inspire Medical Systems, Inc.

Export transactions ↓
Tapewire entity
1186
SEC CIK
0001609550
Parsed reports
589

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2025 Filed Mar 5, 2025 21:47 UTC
Ban RandySee Remarks
SaleCommon Stock 2,236 $185.37 $414,484.86
Disclosure

SEC source: 0001104659-25-020916 · tm258354-2_4seq1.xml · nonDerivative · entry 1

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,970

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:31 UTC
Rondoni JohnChief Technology Officer
Tax withholdingCommon Stock 1,009 $186.45 $188,128.05
Disclosure

SEC source: 0001104659-25-017091 · tm257622-3_4seq1.xml · nonDerivative · entry 2

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,787

F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:31 UTC
Rondoni JohnChief Technology Officer
GrantCommon Stock 3,296 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017091 · tm257622-3_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,796

F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:32 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 8,273 $186.45 $1,542,500.85
Disclosure

SEC source: 0001104659-25-017093 · tm257622-5_4seq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,149

F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:32 UTC
Herbert Timothy P.Director · CEO and President
GrantCommon Stock 18,458 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017093 · tm257622-5_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,422

F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:31 UTC
Phillips Bryan KSee Remarks
Tax withholdingCommon Stock 2,206 $186.45 $411,308.70
Disclosure

SEC source: 0001104659-25-017092 · tm257622-4_4seq1.xml · nonDerivative · entry 2

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,236

F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:31 UTC
Phillips Bryan KSee Remarks
GrantCommon Stock 6,152 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017092 · tm257622-4_4seq1.xml · nonDerivative · entry 1

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,442

F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
Tax withholdingCommon Stock 2,200 $186.45 $410,190.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 7

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,126

F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
GrantCommon Stock 6,152 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 6

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,326

F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:30 UTC
Ban RandySee Remarks
Tax withholdingCommon Stock 2,205 $186.45 $411,122.25
Disclosure

SEC source: 0001104659-25-017089 · tm257622-1_4seq1.xml · nonDerivative · entry 2

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,206

F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.

Read SEC document
February 24, 2025 Filed Feb 26, 2025 02:30 UTC
Ban RandySee Remarks
GrantCommon Stock 6,152 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017089 · tm257622-1_4seq1.xml · nonDerivative · entry 1

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,411

F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units.

Read SEC document
February 21, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 5

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by son

Disclosed balance after: 1,475

Read SEC document
February 21, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 4

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by son

Disclosed balance after: 1,475

Read SEC document
February 21, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 3

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by son

Disclosed balance after: 1,475

Read SEC document
February 21, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 2

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by daughter

Disclosed balance after: 1,475

Read SEC document
February 21, 2025 Filed Feb 26, 2025 02:30 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,174

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:43 UTC
Mann MelissaChief People Officer
GrantCommon Stock 5,076 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014858 · tm256927-3_4seq1.xml · nonDerivative · entry 1

Mann Melissa · CIK 0002031034 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,266

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:42 UTC
Rondoni JohnChief Technology Officer
GrantCommon Stock 5,076 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014857 · tm256927-2_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:48 UTC GrantCommon Stock 5,076 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014870 · tm256927-7_4seq1.xml · nonDerivative · entry 2

Weatherby Carlton · CIK 0001986335 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,457

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:46 UTC
Buchholz RichardChief Financial Officer
GrantCommon Stock 5,076 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014866 · tm256927-6_4seq1.xml · nonDerivative · entry 2

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,674

F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $67.63 $0.00
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · derivative · entry 16

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2029-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: Fully vested and exercisable.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 584 $187.66 $109,593.44
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 13

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,259

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 3,341 $186.96 $624,648.39
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 12

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,843

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.35 to $187.29. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 3,824 $185.84 $710,646.42
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 11

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,184

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.35 to $186.32. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 3,452 $184.81 $637,965.16
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 10

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,008

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.33 to $185.31. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 2,541 $183.79 $467,015.73
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 9

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,460

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.31 to $184.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 3,242 $182.90 $592,946.56
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 8

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,001

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.30 to $183.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 3,770 $181.90 $685,756.97
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 7

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,243

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.30 to $182.26. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 1,330 $180.79 $240,446.71
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 6

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,013

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.29 to $181.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 1,000 $179.41 $179,406.70
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 5

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,343

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.12 to $179.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
SaleCommon Stock 2,500 $178.54 $446,339.50
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 4

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,343

F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.08 to $178.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
Exercise / conversionCommon Stock 25,000 $67.63 $1,690,750.00
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 3

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
GrantCommon Stock 5,076 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 2

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,843

F3 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:45 UTC
Phillips Bryan KSee Remarks
GrantCommon Stock 5,076 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 3

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,290

F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 23:41 UTC
Herbert Timothy P.Director · CEO and President
GrantCommon Stock 16,029 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-014855 · tm256927-1_4seq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,964

F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 13, 2025 Filed Feb 25, 2025 01:03 UTC
Kelly Jason PSee Remarks
GrantCommon Stock 4,541 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-016633 · tm257494-2_4seq1.xml · nonDerivative · entry 1

Kelly Jason P · CIK 0002057473 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,541

F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 11, 2025 Filed Feb 14, 2025 01:14 UTC
Rondoni JohnChief Technology Officer
SaleCommon Stock 583 $170.49 $99,395.67
Disclosure

SEC source: 0001104659-25-013139 · tm256634-1_4seq1.xml · nonDerivative · entry 2

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,424

Read SEC document
February 09, 2025 Filed Feb 14, 2025 01:14 UTC
Rondoni JohnChief Technology Officer
Tax withholdingCommon Stock 315 $182.15 $57,377.25
Disclosure

SEC source: 0001104659-25-013139 · tm256634-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,007

Read SEC document
February 09, 2025 Filed Feb 18, 2025 23:48 UTC Tax withholdingCommon Stock 313 $182.15 $57,012.95
Disclosure

SEC source: 0001104659-25-014870 · tm256927-7_4seq1.xml · nonDerivative · entry 1

Weatherby Carlton · CIK 0001986335 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,381

Read SEC document
February 09, 2025 Filed Feb 18, 2025 23:46 UTC
Buchholz RichardChief Financial Officer
Tax withholdingCommon Stock 314 $182.15 $57,195.10
Disclosure

SEC source: 0001104659-25-014866 · tm256927-6_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,598

F1 · balance_after: Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024.

Read SEC document
February 09, 2025 Filed Feb 18, 2025 23:44 UTC
Ban RandySee Remarks
Tax withholdingCommon Stock 314 $182.15 $57,195.10
Disclosure

SEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 1

Ban Randy · CIK 0001737127 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,767

F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

F2 · balance_after: Includes 25 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2024.

Read SEC document
February 09, 2025 Filed Feb 18, 2025 23:45 UTC
Phillips Bryan KSee Remarks
Tax withholdingCommon Stock 282 $182.15 $51,366.30
Disclosure

SEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 2

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,214

Read SEC document
February 09, 2025 Filed Feb 18, 2025 23:41 UTC
Herbert Timothy P.Director · CEO and President
Tax withholdingCommon Stock 896 $182.15 $163,206.40
Disclosure

SEC source: 0001104659-25-014855 · tm256927-1_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,935

F1 · balance_after: Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024.

Read SEC document
January 29, 2025 Filed Feb 18, 2025 23:45 UTC
Phillips Bryan KSee Remarks
Tax withholdingCommon Stock 204 $189.99 $38,757.96
Disclosure

SEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 1

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,496

F1 · balance_after: Includes (i) 66 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 63 shares acquired under the Plan on December 31, 2024.

Read SEC document
January 15, 2025 Filed Jan 18, 2025 01:16 UTC GrantCommon Stock 80 $176.33 $14,106.40
Disclosure

SEC source: 0001104659-25-004601 · tm253739-3_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,293

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 15, 2025 Filed Jan 18, 2025 02:19 UTC GrantCommon Stock 137 $176.33 $24,157.21
Disclosure

SEC source: 0001104659-25-004609 · tm253739-2_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,426

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 15, 2025 Filed Jan 18, 2025 01:17 UTC GrantCommon Stock 92 $176.33 $16,222.36
Disclosure

SEC source: 0001104659-25-004602 · tm253739-4_4seq1.xml · nonDerivative · entry 1

Broader Shelley G. · CIK 0001426843 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,592

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 15, 2025 Filed Jan 18, 2025 01:15 UTC GrantCommon Stock 81 $176.33 $14,282.73
Disclosure

SEC source: 0001104659-25-004600 · tm253739-1_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,512

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:05 UTC
Rondoni JohnChief Technology Officer
SaleCommon Stock 58 $215.00 $12,470.00
Disclosure

SEC source: 0001104659-25-002532 · tm252955-1_4seq1.xml · nonDerivative · entry 1

Rondoni John · CIK 0001932219 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,322

F1 · balance_after: Includes 32 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated November 5, 2024.

Read SEC document
December 20, 2024 Filed Dec 23, 2024 21:15 UTC
Herbert Timothy P.Director · CEO and President
OtherStock Option (Right to Buy) · Derivative 2,915 Not disclosed Strike: $227.53 Not disclosed
Disclosure

SEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · derivative · entry 9

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 5,553

Underlying: Common Stock · 2,915 shares

Expires 2030-12-14

F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions.

F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions.

F5 · derivative.exercise_date: The original grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F1 · balance_after: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions.

F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.